COMPANY OVERVIEW
SMARTECH TOPICAL is a specialty pharmaceutical company initially focused on the topical NSAID (Non-Steroidal Anti-Inflammatory Drug) market. The company’s initial focus is to develop products that treat chronic pain conditions like OA (Osteo Arthritis) and Musculoskeletal pain that are not being adequately addressed or those where current therapies and approaches are suboptimal.
Our strategy is to bring new products to market through a licensing/partnering strategy by identifying optimal delivery mechanisms and/or alternative applications for FDA-approved or well characterized active pharmaceutical ingredients (APIs). We aim to reduce the time, cost, and risk profile typically associated with new product development by utilizing active ingredients with demonstrated safety profiles and taking advantage of the expedited regulatory pathways, such as Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act.
We deploy a market-driven approach to identify the limitations of current treatment options and work to develop products that may address these limitations in areas of efficacy, safety, and/or patient experience.
